Dysregulation of the inflammatory response to the parasite, Toxoplasma gondii, in P2X7 receptor-deficient mice

International Journal for Parasitology

Volumn 41, Issue 3, 2011, Pages 301-308

  Miller, Catherine M ^a   Zakrzewski, Alana M ^a   Ikin, Rowan J ^a   Boulter, Nicola R ^a   Katrib, Marilyn ^a   Lees, Michael P ^a   Fuller, Stephen J ^b   Wiley, James S ^b   Smith, Nicholas C ^a  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Apicomplexa; IL 10; Immunopathology; Nitric oxide; P2X7 receptor; Toxoplasma gondii

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; PURINERGIC P2X7 RECEPTOR; TUMOR NECROSIS FACTOR;

IMMUNE RESPONSE; MEMBRANE; NITRIC OXIDE; PARASITE; PATHOGEN; PATHOLOGY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOPATHOGENESIS; INFECTION SENSITIVITY; INFLAMMATION; KNOCKOUT GENE; LIVER PARENCHYMA; MALE; MOUSE; NONHUMAN; PARASITE LOAD; PARASITE VIRULENCE; PERITONEAL EXUDATE CELL; PROTEIN SYNTHESIS; SPLEEN CELL; STRAIN DIFFERENCE; TOXOPLASMA GONDII; TOXOPLASMOSIS; WEIGHT REDUCTION;

ANIMALS; DISEASE SUSCEPTIBILITY; INFLAMMATION; INTERLEUKIN-10; LIVER; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE; RECEPTORS, PURINERGIC P2X7; SPECIES SPECIFICITY; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; WEIGHT LOSS;

APICOMPLEXA; MUS; TOXOPLASMA GONDII;

EID: 79951813574     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2010.10.001     Document Type: Article

References (49)

1. Adriouch S., Dox C., Welge V., Seman M., Koch-Noble F., Haag F. A natural P451L mutation in the cytoplasmic domain impairs the function of the mouse P2X7 receptor. J. Immunol. 2002, 169:4108-4112.
2. Aga M., Watters J.J., Pfeiffer Z.A., Wiepz G.J., Sommer J.A., Bertics P.J. Evidence for nucleotide receptor modulation of cross talk between MAP kinase and NF-κB signaling pathways in murine RAW 264.7 macrophages. Am. J. Physiol. Cell Physiol. 2004, 286:C923-C930.
3. Aliberti J. Host persistence. Exploitation of anti-inflammatory pathways by Toxoplasma gondii. Nat. Rev. Immunol. 2005, 5:162-170.
4. Araujo F.G., Williams D.M., Grumet F.C., Remington J.S. Strain-dependent differences in murine susceptibility to Toxoplasma. Infect Immun. 1976, 13:1528-1530.
5. Asward F., Dennert G. P2X7 receptor expression levels determine lethal effects of a purine based danger signal in T lymphocytes. Cell. Immunol. 2006, 243:58-65.
6. Boyle J.P., Saeij J.P., Boothroyd J.C. Toxoplasma gondii: inconsistent dissemination patterns following oral infection in mice. Exp. Parasitol. 2007, 116:302-305.
7. Brunet L.R. Nitric oxide in parasitic infections. Int. Immunopharmacol. 2001, 1:1457-1467.
8. Chavez S.P., Torres-Santos E.C., Marques C., Figliuolo V.R., Persechini P.M., Coutinho-Silva R., Rossi-Bergmann B. Modulation of P2X7 purinergic receptor in macrophages by Leishmania amazonensis and its role in parasite elimination. Microbes Infect. 2009, 11:842-849.
9. Chen L., Brosnan C.F. Regulation of immune response by P2X7 receptor. Crit. Rev.Immunol. 2006, 26:499-513.
10. Correa G., da Silva C.M., Moreira-Souza A.C., Vommaro R.C., Coutinho-Silva R. Activation of the P2X7 receptor triggers the elimination of Toxoplasma gondii tachyzoites from infected macrophages. Microbes Infect. 2010, 12:497-504.
11. Coutinho-Silva R., Monteiro da Cruz C., Persechini P.M., Ojcius D.M. The role of P2 receptors in controlling infections by intracellular pathogens. Purinergic Signal. 2007, 3:83-90.
12. Coutinho-Silva R., Perfettini J.-L., Perrsechini P.M., Dautry-Varsat A., Ojcius D.M. Modulation of P2Z/P2X7 receptor activity in macrophages infected with Chlamydia psittaci. Am. J. Physiol. Cell Physiol. 2001, 280:C81-C89.
13. Coutinho-Silva R., Stahl L., Raymond M.-N., Jungas T., Verbecke P., Burnstock G., Darville T., Ojcius D.M. Inhibition of chlamydial infectious activity due to P2X7R-dependent phospholipase D activation. Immunity 2003, 19:403-412.
14. Darville T., Welter-Stahl L., Cruz C., Sater A.A., Andrews C.W., Ojcius D.M. Effect of the purinergic receptor P2X7 on Chlamydia infection in cervical epithelial cells and vaginally infected mice. J. Immunol. 2007, 179:3707-3714.
15. Fairbairn I.P., Stober C.B., Kumararatne D.S., Lammas D.A. ATP-mediated killing of intracellular mycobacteria by macrophages is a P2X7-dependent process inducing bacterial death by phagosome-lysosome fusion. J. Immunol. 2001, 167:3300-3307.
16. Fernando S.L., Saunders B.M., Sluyter R., Skarratt K.K., Goldberg H., Marks G.B., Wiley J.S., Britton W.J. A polymorphism in the P2X7 gene increases susceptibility to extrapulmonary tuberculosis. Am. J. Res. Crit. Care Med. 2007, 175:360-366.
17. Fernando S.L., Saunders B.M., Sluyter R., Skarratt K.K., Wiley J.S., Britton W.J. Gene dosage determines the negative effects of polymorphic alleles of the P2X7 receptor on adenosine triphosphate-mediated killing of mycobacteria by human macrophages. J. Infect. Dis. 2005, 192:149-155.
18. Ferrari D., Los M., Bauer M.K., Vandenabeele P., Wesselborg S., Schulze-Osthoff K. P2Z purinoreceptor ligation induces activation of caspases with distinct roles in apoptosis and necrotic alterations of cell death. FEBS Lett. 1999, 447:71-75.
19. Ferrari D., Wesselborg S., Bauer M.K., Schulze-Osthoff K. Extracellular ATP activates transcription factor NF-kappaB through the P2Z purinoreceptor by selectively targeting NF-kappBp65. J. Cell. Biol. 1997, 29:1635-1643.
20. Fouts A.E., Boothroyd J.C. Infection with Toxoplasma gondii bradyzoites has a diminished impact on host transcript levels relative to tachyzoite infection. Infect. Immun. 2007, 75:634-642.
21. + T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J. Immunol. 1996, 157:798-805.
22. Hewinson J., Moore S.F., Glover C., Watts A.G., MacKenzie A.B. A key role for redox signaling in rapid P2X7 receptor-induced IL-1β processing in human monocytes. J. Immunol. 2008, 180:8410-8420.
23. Hong S., Schwarz N., Brass A., Seman M., Haag F., Koch-Nolt F., Schilling W.P., Dubyak G.R. Differential regulation of P2X7 receptor activation by extracellular nicotinamide adenine dinucleotide and ecto-ADP-ribosyltransferases in murine macrophages and T cells. J. Immunol. 2009, 183:578-592.
24. Johnson A.M. Strain-dependent, route of challenge-dependent, murine susceptibility to toxoplasmosis. Z. Parasitenkd. 1984, 70:303-309.
25. Kusner D.J., Adams J. ATP-induced killing of virulent Mycobacterium tuberculosis within human macrophages requires phospholipase D. J. Immunol. 2000, 164:379-388.
26. Lammas D.A., Stober C., Harvey C.J., Kendrick N., Panchalingam S., Kumararatne D.S. ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z (P2X7) receptors. Immunity 1997, 7:433-444.
27. Le Stunff H., Auger R., Kanellopoulos J., Raymond M.-N. The Pro-451 to Leu polymorphism within the C-terminal tail of the P2X7 receptor impairs cell death but not phospholipase D activation in murine thymocytes. J. Biol. Chem. 2004, 279:16918-16926.
28. Lees M.P., Fuller S.J., McLeod R., Boulter N.R., Miller C.M., Zakrzewski A.M., Mui E.J., Witola W.H., Coyne J.J., Hargrave A.C., Jamieson S.E., Blackwell J.M., Wiley J.S., Smith N.C. P2X7 receptor-mediated killing of an intracellular parasite, Toxoplasma gondii, by human and murine macrophages. J. Immunol. 2010, 184:7040-7046.
29. Lenertz L.Y., Gavala M.L., Hill L.M., Bertics P.J. Cell signaling via the P2X7 nucleotide receptor: linkage to ROS production, gene transcription, and receptor trafficking. Purinergic Signal. 2009, 5:175-187.
30. McLeod R., Eisenhauer P., Mack D., Brown C., Filice G., Spitalny G. Immune responses associated with early survival after peroral infection with Toxoplasma gondii. J. Immunol. 1989, 142:3247-3255.
31. Miller C.M., Akratos C., Johnson A.M., Smith N.C. The production of a 70 kDa heat shock protein by Toxoplasma gondii in immunocompromised mice. Int. J. Parasitol. 2000, 30:1467-1473.
32. Miller C.M., Boulter N.R., Ikin R.J., Smith N.C. The immunobiology of the innate response to Toxoplasma gondii. Int. J. Parasitol. 2009, 39:23-39.
33. Miller C.M., Smith N.C., Ikin R.J., Boulter N.R., Dalton J.P., Donnelly S. Immunological interactions between two common pathogens, the Th1-inducing protozoan Toxoplasma gondii and the Th2-inducing helminth Fasciola hepatica. PLoS ONE 2009, 4:e5692.
34. Molloy A., Laochumroonvorapong P., Kaplan G. Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular Bacillus Calmette-Guerin. J. Exp. Med. 1994, 180:1499-1509.
35. Montoya J.G., Liesenfeld O. Toxoplasmosis. Lancet 2004, 363:1965-1976.
36. Mosser D.M. The many faces of macrophage activation. J. Leukoc. Biol. 2003, 73:209-212.
37. Nino-Moreno P., Portales-Perez D., Hernandez-Castro B., Portales-Cervantes L., Flores-Meraz V., Baranda L., Gomez-Gomez A., Acuna-Alonzo V., Granados J., Gonzalez-Amaro R. P2X7 and NRAMP1/SLC11 A1 gene polymorphisms in Mexican mestizo subjects with pulmonary tuberculosis. Clin. Exp. Immunol. 2007, 148:469-477.
38. Placido R., Auricchio G., Falzoni S., Battistini L., Colizzi V., Brunetti E., Di Virgilio F., Mancino G. P2X7 purinergic receptors and extracellular ATP mediate apoptosis of human monocytes/macrophages infected with Mycobacterium tuberculosis reducing the intracellular bacterial viability. Cell. Immunol. 2006, 244:10-18.
39. Robben P.M., Mordue D.G., Truscott S.M., Takeda K., Akira S., Sibley L.D. Production of IL-12 by macrophages infected with Toxoplasma gondii depends on the parasite genotype. J. Immunol. 2004, 172:1686-1694.
40. Saunders B.M., Fernando S.L., Sluyter R., Britton W.J., Wiley S.J. A loss-of-function polymorphism in the human P2X7 receptor abolishes ATP-mediated killing of mycobacteria. J. Immunol. 2003, 171:5442-5446.
41. Shemon A.N., Sluyter R., Fernando S.L., Clarke A.L., Dao-Ung L.-P., Skarratt K.K., Saunders B.M., Tan K.S., Gu B.J., Fuller S.J., Britton W.J., Petrou S., Wiley J.S. A Thr357 to Ser polymorphism in homozygous and compound heterozygous subjects causes absent or reduced P2X7 function and impairs ATP-induced mycobacterial killing by macrophages. J. Biol. Chem. 2006, 281:2079-2086.
42. Sluyter R., Dalitz J.G., Wiley J.S. P2X7 receptor polymorphism impairs extracellular adenosine 5-triphosphate-induced interleukin-18 release from human monocytes. Genes Immun. 2004, 5:588-591.
43. Sluyter R., Shemon A.N., Wiley J.S. Glu-496 Ala polymorphism in the P2X7 receptor impairs ATP-induced IL-1β release from human monocytes. J. Immunol. 2004, 172:3399-3405.
44. Stober C.B., Lammas D.A., Li C.M., Kumararatne D.K., Lightman S.L., McArdle C.A. ATP-mediated killing of Mycobacterium bovis Bacille Calmette-Guerin within human macrophages is calcium dependent and associated with the acidification of mycobacteria-containing phagosomes. J. Immunol. 2001, 166:6276-6286.
45. Suadicani, S.O., Iglesias, R., Spray, D.C., Scemes, E., 2009. Point mutation in the mouse P2X7 receptor affects intercellular calcium waves in astrocytes. ASN NEURO 1(1), art: e00005. doi:10.1042/AN20090001.
46. Suzuki Y., Sher A., Yap G., Park D., Neyer L.E., Liesenfeld O., Fort M., Kang H., Gufwoli E. IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57Bl/6 mice following peroral infection with Toxoplasma gondii. J. Immunol. 2000, 164:5375-5382.
47. Tsukimoto M., Maehata M., Harada H., Ikari A., Takagi K., Degawa M. P2X7 receptor-dependent cell death is modulated during murine T cell maturation and mediated by dual signalling pathways. J. Immunol. 2006, 177:2842-2850.
48. Wiley J.S., Gu B.J., Zhang W., Worthington R.A., Dao-Ung P., Shemon A., Sluyter R., Liang S., Barden J.A. Genetic polymorphisms of the human P2X7 receptor and relationship to function. Drug Dev. Res. 2001, 53:72-76.
49. Yip L., Woehrle T., Corriden R., Hirsh M., Chen Y., Inoue Y., Ferrari V., Insel P.A., Junger W.G. Autocrine regulation of T-cell activation by ATP release and P2X7 receptors. FASEB J. 2009, 23:1685-1693.